These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 28531770)

  • 1. Treatment consumption and treatment re-enrollment in GHB-dependent patients in The Netherlands.
    van Noorden MS; Mol T; Wisselink J; Kuijpers W; Dijkstra BAG
    Drug Alcohol Depend; 2017 Jul; 176():96-101. PubMed ID: 28531770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sociodemographic and substance use characteristics of γ hydroxybutyrate (GHB) dependent inpatients and associations with dependence severity.
    Brunt TM; Koeter MW; Hertoghs N; van Noorden MS; van den Brink W
    Drug Alcohol Depend; 2013 Aug; 131(3):316-9. PubMed ID: 23332440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detoxification with titration and tapering in gamma-hydroxybutyrate (GHB) dependent patients: The Dutch GHB monitor project.
    Dijkstra BA; Kamal R; van Noorden MS; de Haan H; Loonen AJ; De Jong CA
    Drug Alcohol Depend; 2017 Jan; 170():164-173. PubMed ID: 27923198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decision rules for GHB (γ-hydroxybutyric acid) detoxification: a vignette study.
    Kamal RM; van Iwaarden S; Dijkstra BA; de Jong CA
    Drug Alcohol Depend; 2014 Feb; 135():146-51. PubMed ID: 24380737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk assessment of gamma-hydroxybutyric acid (GHB) in the Netherlands.
    van Amsterdam JG; van Laar M; Brunt TM; van den Brink W
    Regul Toxicol Pharmacol; 2012 Jun; 63(1):55-63. PubMed ID: 22440552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tapering with Pharmaceutical GHB or Benzodiazepines for Detoxification in GHB-Dependent Patients: A Matched-Subject Observational Study of Treatment-as-Usual in Belgium and The Netherlands.
    Beurmanjer H; Luykx JJ; De Wilde B; van Rompaey K; Buwalda VJA; De Jong CAJ; Dijkstra BAG; Schellekens AFA
    CNS Drugs; 2020 Jun; 34(6):651-659. PubMed ID: 32319006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk assessment of GBL as a substitute for the illicit drug GHB in the Netherlands. A comparison of the risks of GBL versus GHB.
    van Amsterdam J; Brunt T; Pennings E; van den Brink W
    Regul Toxicol Pharmacol; 2014 Nov; 70(2):507-13. PubMed ID: 25204614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of craving for and abuse of gamma-hydroxybutyric acid (GHB) in different populations of treated alcoholics: an open comparative study.
    Caputo F; Francini S; Stoppo M; Lorenzini F; Vignoli T; Del Re A; Comaschi C; Leggio L; Addolorato G; Zoli G; Bernardi M
    J Psychopharmacol; 2009 Nov; 23(8):883-90. PubMed ID: 18635689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of Gamma-Hydroxybutyric Acid-Use and Gamma-Hydroxybutyric Acid-Induced Coma on Affect and the Affective Network.
    Raposo Pereira F; McMaster MTB; de Vries YDAT; Polderman N; van den Brink W; van Wingen GA
    Eur Addict Res; 2019; 25(4):173-181. PubMed ID: 30999293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baclofen as relapse prevention in the treatment of Gamma- Hydroxybutyrate (GHB) dependence: an open label study.
    Kamal RM; Schellekens A; De Jong CA; Dijkstra BA
    BMC Psychiatry; 2015 Apr; 15():91. PubMed ID: 25927622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of Co-occurring Substance Use on Gamma-hydroxybutyric Acid Withdrawal Syndrome.
    Kamal RM; Dijkstra BA; Loonen AJ; De Jong CA
    J Addict Med; 2016; 10(4):229-35. PubMed ID: 27310146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological Treatment in γ-Hydroxybutyrate (GHB) and γ-Butyrolactone (GBL) Dependence: Detoxification and Relapse Prevention.
    Kamal RM; van Noorden MS; Wannet W; Beurmanjer H; Dijkstra BA; Schellekens A
    CNS Drugs; 2017 Jan; 31(1):51-64. PubMed ID: 28004314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ["Liquid ecstasy" (GHB): a recreational drug? Bio-psycho-social clinical profile of the consumer and some therapeutic proposals].
    Royo-Isaach J; Magrané M; Vilà R; Capdevila ME
    Aten Primaria; 2004 May; 33(9):516-20. PubMed ID: 15207152
    [No Abstract]   [Full Text] [Related]  

  • 14. Relative abuse liability of gamma-hydroxybutyric acid, flunitrazepam, and ethanol in club drug users.
    Abanades S; Farré M; Barral D; Torrens M; Closas N; Langohr K; Pastor A; de la Torre R
    J Clin Psychopharmacol; 2007 Dec; 27(6):625-38. PubMed ID: 18004131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gamma-hydroxybutyric acid (GHB): more than a date rape drug, a potentially addictive drug].
    Karila L; Novarin J; Megarbane B; Cottencin O; Dally S; Lowenstein W; Reynaud M
    Presse Med; 2009 Oct; 38(10):1526-38. PubMed ID: 19762202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Forensic cases involving the use of GHB in The Netherlands.
    Bosman IJ; Lusthof KJ
    Forensic Sci Int; 2003 Apr; 133(1-2):17-21. PubMed ID: 12742684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in gamma-hydroxybutyrate (GHB) and related drug intoxication: 1999 to 2003.
    Anderson IB; Kim SY; Dyer JE; Burkhardt CB; Iknoian JC; Walsh MJ; Blanc PD
    Ann Emerg Med; 2006 Feb; 47(2):177-83. PubMed ID: 16431231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inpatient Gamma-Hydroxybutyrate Detoxification: A Case Report Describing Day-to-day Therapeutic Management.
    von Theobald L; Rousselet M; Cholet J; Debar H; Boels D; Victorri-Vigneau C; Grall-Bronnec M
    J Addict Med; 2017; 11(3):231-234. PubMed ID: 28125446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GHB pharmacology and toxicology: acute intoxication, concentrations in blood and urine in forensic cases and treatment of the withdrawal syndrome.
    Busardò FP; Jones AW
    Curr Neuropharmacol; 2015 Jan; 13(1):47-70. PubMed ID: 26074743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gamma-hydroxybutyrate detoxification by titration and tapering.
    de Jong CA; Kamal R; Dijkstra BA; de Haan HA
    Eur Addict Res; 2012; 18(1):40-5. PubMed ID: 22142784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.